Maxine Gowen

Dr. Maxine Gowen is a Chairman at Passage Bio, Inc. and an Independent Director at Aclaris Therapeutics, Inc. She is on the Board of Directors at TamuroBio, Inc., Aclaris Therapeutics, Inc. and Conforma Therapeutics Corp.
Dr. Gowen was previously employed as an Independent Non-Executive Director by Merus NV, an Independent Director by Idera Pharmaceuticals, Inc., an Independent Director by Aceragen, Inc., an Independent Director by Akebia Therapeutics, Inc., an Independent Director by Human Genome Sciences, Inc., a SVP-External Drug Discovery Excellence Center by GlaxoSmithKline Plc, a President & Managing Partner by SR One Ltd., a VP-Drug Discovery & Musculoskeletal Diseases by GlaxoSmithKline Plc, a Head-Bone Cell Biology Group by University of Bath, and a Senior Vice President by Center of Excellence For External Drug Discovery.
She also served on the board at Panorama Medicine, Inc., Life Sciences Pennsylvania, Biotechnology Innovation Organization, Trevena, Inc., Azelon Pharmaceuticals, Inc., Morphotek, Inc. and Santarus, Inc. She received her undergraduate degree from the University of Bristol, an MBA from The Wharton School of the University of Pennsylvania, a doctorate degree from the University of Bath and a doctorate degree from The University of Sheffield.